Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 77.91

+1.5%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2097)	1/7/2008 12:37:22 PM
From: Jibacoa	Read Replies (2) of 3722

MNKD Was up 18.4% earlier, but is up only 9.75% at present.<g> bigcharts.marketwatch.com It will be presenting tomorrow at the JPMorgan Health Care conference in Frisco. MNKD supposedly is developing products for diabetes & cancer. Its MKC1106-PP is a DNA vector with two synthetic peptides delivered via a plasmid prime-peptide boost treatment.It is in a PI designed to target two tumor-specific antigens, preferential antigen of melanoma (PRAME) and prostate specific membrane antigen (PSMA). The stock made an all time L on Friday. It trades around 1.0xBV with a negative CF of > $4.40 & a short ratio around 26x its ADV,in spite that it came down some in the last month.<g> Although MNKD has trimmed some its losses in the last 2Qs, it seems it will have a hard time going over its resistance above the $8.85 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next